Literature DB >> 9102060

Quality of life as outcome in the treatment of osteoporosis: the development of a questionnaire for quality of life by the European Foundation for Osteoporosis.

P Lips1, C Cooper, D Agnusdei, F Caulin, P Egger, O Johnell, J A Kanis, U Liberman, H Minne, J Reeve, J Y Reginster, M C de Vernejoul, I Wiklund.   

Abstract

The morbidity of osteoporosis is caused by fractures. Vertebral fractures lead to pain and disability and a decrease in quality of life. A Working Party of the European Foundation for Osteoporosis has developed a specific questionnaire for patients with established vertebral osteoporosis. This questionnaire is intended for use in clinical trials. The questionnaire consists of questions and visual analogue scales in the following domains: pain, activities of daily living, jobs around the house, mobility, leisure and social activities, general health perception and mood. The questionnaire has been translated from English into French, German, Italian, Hebrew, Swedish and Dutch. The questionnaire is currently being validated in a multicentre study involving patients with stable osteoporosis and control subjects. Preliminary results indicate that the reproducibility is sufficient and that the questionnaire is able to discriminate between patients with vertebral osteoporosis and control subjects.

Entities:  

Mesh:

Year:  1997        PMID: 9102060     DOI: 10.1007/bf01623457

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  10 in total

1.  Quality of life measures in health care. I: Applications and issues in assessment.

Authors:  R Fitzpatrick; A Fletcher; S Gore; D Jones; D Spiegelhalter; D Cox
Journal:  BMJ       Date:  1992-10-31

2.  Quality of life measures in health care. II: Design, analysis, and interpretation.

Authors:  A Fletcher; S Gore; D Jones; R Fitzpatrick; D Spiegelhalter; D Cox
Journal:  BMJ       Date:  1992-11-07

3.  Quality of life and vertebral osteoporosis.

Authors:  J A Kanis; W H Minne; P J Meunier; R Ziegler; E Allender
Journal:  Osteoporos Int       Date:  1992-07       Impact factor: 4.507

4.  Recommendations for the registration of new chemical entities used in the prevention and treatment of osteoporosis.

Authors:  J Y Reginster; J E Compston; E A Jones; J M Kaufman; M Audran; G Bouvenot; L Frati; G Mazzuoli; C Gennari; E M Lemmel
Journal:  Calcif Tissue Int       Date:  1995-10       Impact factor: 4.333

5.  Measuring health status: a new tool for clinicians and epidemiologists.

Authors:  S M Hunt; J McEwen; S P McKenna
Journal:  J R Coll Gen Pract       Date:  1985-04

6.  The Sickness Impact Profile: development and final revision of a health status measure.

Authors:  M Bergner; R A Bobbitt; W B Carter; B S Gilson
Journal:  Med Care       Date:  1981-08       Impact factor: 2.983

7.  The Mediterranean Osteoporosis (MEDOS) Study questionnaire.

Authors:  J Dequeker; J Ranstam; J Valsson; B Sigurgevisson; E Allander
Journal:  Clin Rheumatol       Date:  1991-03       Impact factor: 2.980

8.  Guidelines for clinical trials in osteoporosis. A position paper of the European Foundation for Osteoporosis and Bone Disease.

Authors:  J A Kanis; P Geusens; C Christiansen
Journal:  Osteoporos Int       Date:  1991-06       Impact factor: 4.507

9.  Validating the SF-36 health survey questionnaire: new outcome measure for primary care.

Authors:  J E Brazier; R Harper; N M Jones; A O'Cathain; K J Thomas; T Usherwood; L Westlake
Journal:  BMJ       Date:  1992-07-18

10.  A study of complaints and their relation to vertebral destruction in patients with osteoporosis.

Authors:  G Leidig; H W Minne; P Sauer; C Wüster; J Wüster; M Lojen; F Raue; R Ziegler
Journal:  Bone Miner       Date:  1990-03
  10 in total
  56 in total

Review 1.  Tolerability profile of SERMs.

Authors:  D Agnusdei; N Iori
Journal:  J Endocrinol Invest       Date:  1999-09       Impact factor: 4.256

2.  Community-based exercise program reduces risk factors for falls in 65- to 75-year-old women with osteoporosis: randomized controlled trial.

Authors:  Nick D Carter; Karim M Khan; Heather A McKay; Moira A Petit; Constance Waterman; Ari Heinonen; Patti A Janssen; Meghan G Donaldson; Arthur Mallinson; Lenore Riddell; Karen Kruse; Jerilynn C Prior; Leon Flicker
Journal:  CMAJ       Date:  2002-10-29       Impact factor: 8.262

Review 3.  Pharmaceutical care and health related quality of life outcomes over the past 25 years: Have we measured dimensions that really matter?

Authors:  Mohammed A Mohammed; Rebekah J Moles; Timothy F Chen
Journal:  Int J Clin Pharm       Date:  2018-01-10

4.  Impact of vertebral deformities, osteoarthritis, and other chronic diseases on quality of life: a population-based study.

Authors:  N M van Schoor; J H Smit; J W R Twisk; P Lips
Journal:  Osteoporos Int       Date:  2004-10-12       Impact factor: 4.507

5.  Cross-geographic region differences in quality of life in women with and without vertebral fracture.

Authors:  N M van Schoor; H Yu; J Bobula; P Lips
Journal:  Osteoporos Int       Date:  2009-02-24       Impact factor: 4.507

6.  Effect of low-intensity back exercise on quality of life and back extensor strength in patients with osteoporosis: a randomized controlled trial.

Authors:  M Hongo; E Itoi; M Sinaki; N Miyakoshi; Y Shimada; S Maekawa; K Okada; Y Mizutani
Journal:  Osteoporos Int       Date:  2007-06-16       Impact factor: 4.507

7.  New perspectives on the definition and the management of severe osteoporosis: the patient with two or more fragility fractures.

Authors:  R Nuti; M L Brandi; G Isaia; U Tarantino; S Silvestri; S Adami
Journal:  J Endocrinol Invest       Date:  2009-10       Impact factor: 4.256

8.  Impact of postural deformities and spinal mobility on quality of life in postmenopausal osteoporosis.

Authors:  N Miyakoshi; E Itoi; M Kobayashi; H Kodama
Journal:  Osteoporos Int       Date:  2003-10-14       Impact factor: 4.507

9.  A randomized control trial on the effectiveness of osteopathic manipulative treatment in reducing pain and improving the quality of life in elderly patients affected by osteoporosis.

Authors:  Liria Papa; Alfonso Mandara; Michele Bottali; Vincenzo Gulisano; Stefano Orfei
Journal:  Clin Cases Miner Bone Metab       Date:  2012-12-20

10.  Strontium ranelate prevents quality of life impairment in post-menopausal women with established vertebral osteoporosis.

Authors:  P Marquis; C Roux; C de la Loge; M Diaz-Curiel; C Cormier; G Isaia; J Badurski; J Wark; P J Meunier
Journal:  Osteoporos Int       Date:  2007-10-11       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.